Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-03-24 | Michael F. Mahoney (I)President and CEO, Boston Scientific Corporation Age 51 Director of Baxter since 2015 ... Significant knowledge of the global medical products business ... Audit Committee Member, Compensation Committee Member ... 2015 compensation total $118,345. |
| 2017-03-17 | Mr. Mahoney is Chairman, President and Chief Executive Officer of Boston Scientific Corporation (Boston Scientific). The Compensation Committee is currently composed of John D. Forsyth (Chair), Peter S. Hellman, Michael F. Mahoney, Carole J. Shapazian and Thomas T. Stallkamp, each of whom is independent under the rules of the NYSE. |
| 2018-03-23 | Mr. Mahoney is Chairman, President and Chief Executive Officer of Boston Scientific Corporation ... Committees: Compensation and Quality, Compliance and Technology. ... 2017 compensation for non-employee directors: $285,059. |
| 2019-03-26 | Mr. Mahoney is Chairman, President and Chief Executive Officer of Boston Scientific Corporation. ... Committees: Compensation and Quality, Compliance and Technology. ... Director Compensation Table shows total compensation of $301,015. |
| 2020-03-17 | Mr. Mahoney is Chairman, President and Chief Executive Officer of Boston Scientific Corporation. ... Committees: Compensation and Quality, Compliance and Technology. ... Director Compensation Table shows total compensation of $314,944. |
| 2021-03-22 | Mr. Mahoney is Chairman, President and CEO of Boston Scientific Corporation ... Committees: Compensation and Quality, Compliance and Technology. 2020 compensation: $311,445. |
| 2022-03-21 | Mr. Mahoney is the Chairman, President and CEO of Boston Scientific Corporation. Committees: Compensation and Nominating, Corporate Governance & Public Policy. |
| 2023-03-23 | Significant knowledge of the global medical products business and extensive experience leading and operating within global, multi-faceted medical products companies. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-03-25 | Michael F. Mahoney CEO, Chairman of the Board President and Chief Executive Officer of Boston Scientific Corporation Director Since: November 2012 Age: 55 Other Public Company Boards: Baxter International, Inc. Education: University of Iowa, B.B.A. in Finance; Wake Forest University, M.B.A. |
| 2021-03-24 | Michael F. Mahoney CEO, Chairman of the Board President and Chief Executive Officer Director Since: November 2012 Age: 56 Other Public Company Boards: Baxter International, Inc. Education: University of Iowa, B.B.A. in Finance; Wake Forest University, M.B.A. |
| 2022-03-23 | Michael F. Mahoney joined the Company as our president in October 2011 and became our president and chief executive officer and a director in November 2012. Mr. Mahoney became our chairman of the Board in May 2016. |
| 2023-03-22 | Michael F. MahoneyCEO, Chairman of the Board Age:58 President and Chief Executive Officer of Boston Scientific Corporation Director since: November 2012 Other Current Public Boards: Baxter International Inc. Education: University of Iowa, B.B.A. in Finance; Wake Forest University, M.B.A. Employee Directors receive no compensation for serving on the Board or Board committees. Accordingly, Mr. Mahoney did not receive any compensation related to his services as a director in 2022. |
| 2024-03-20 | Michael F. Mahoney CEO, Chairman of the Board Age: 59 President and Chief Executive Officer, Boston Scientific Corporation Director Compensation Directors who are also employees of the Company receive no compensation for serving on the Board or Board committees. Accordingly, Mr. Mahoney did not receive any compensation related to his services as a director in 2023. |
| 2025-03-19 | Michael F. Mahoney CEO, Chairman of the Board Age: 60 President and Chief Executive Officer, Boston Scientific Corporation Director since: November 2012; Chairman since May 2016 ... Mr. Mahoney did not receive any compensation related to his services as a director in 2024. His compensation as an executive of the Company is discussed in the Compensation Discussion & Analysis and the Executive Compensation sections in this Proxy Statement. |
| Filing Date | Source Excerpt |
|---|---|
| 2024-04-05 | Mr. Mahoney has extensive experience leading global, medical products companies ... Mr. Mahoney also has significant knowledge of the global medical products business and extensive experience leading and operating within global, multi-faceted medical products companies as a result of his roles at Boston Scientific and Johnson & Johnson. |
| 2025-04-04 | Mr. Mahoney has been the President, CEO and Chairman of Boston Scientific Corporation ... He has extensive experience leading global medical products companies ... The Board believes he is well positioned to provide constructive, independent and informed guidance and oversight to management as Lead Independent Director and Chair of the Nominating and Corporate Governance Committee. |
Data sourced from SEC filings. Last updated: 2026-02-03